SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021

Han, H; Letourneau, ID; Abate, YH; Abdelmasseh, M; Abu-Gharbieh, E; Adane, TD; Ahinkorah, BO; Ahmad, A; Ahmadi, A; Ahmed, A; et al. Han, H; Letourneau, ID; Abate, YH; Abdelmasseh, M; Abu-Gharbieh, E; Adane, TD; Ahinkorah, BO; Ahmad, A; Ahmadi, A; Ahmed, A; Alhalaiqa, FN; Al-Sabah, SK; Al-Worafi, YM; Amu, H; Andrei, CL; Anoushiravani, A; Arabloo, J; Aravkin, AY; Ashraf, T; Azadnajafabad, S; Baghcheghi, N; Bagherieh, S; Bantie, BB; Bardhan, M; Basile, G; Bayleyegn, NS; Behnoush, AH; Bekele, A; Bhojaraja, VS; Bijani, A; Biondi, A; Burkart, K; Dinh-Toi, C; Chukwu, IS; Cruz-Martins, N; Dai, X; Demessa, BH; Dhali, A; Diaz, D; Thanh, CD; Dodangeh, M; Dongarwar, D; Dsouza, HL; Ekholuenetale, M; Ekundayo, TC; El Sayed, I; Elhadi, M; Fagbamigbe, AF; Fakhradiyev, IR; Ferrara, P; Fetensa, G; Fischer, F; Gebrehiwot, M; Getachew, M; Golechha, M; Gupta, VK; Habib, JR; Hadi, NR; Haep, N; Haile, TG; Hamilton, EB; Hasan, I; Hasani, H; Hassanzadeh, S; Haubold, J; Hay, SI; Hayat, K; Ilesanmi, OS; Inamdar, S; Iwu, CCD; Iyasu, AN; Jayarajah, U; Jayaram, S; Jokar, M; Jomehzadeh, N; Joseph, A; Joseph, N; Joshua, CE; Kabir, A; Kandel, H; Kauppila, JH; Bohan, PMK; Khajuria, H; Khan, M; Khatatbeh, H; Kim, MS; Kisa, A; Kompani, F; Koohestani, HR; Kumar, R; Thao, TTL; Lee, M; Lee, SW; Li, M-C; Lim, SS; Lo, C-H; Lunevicius, R; Malhotra, K; Maugeri, A; Mediratta, RP; Meretoja, TJ; Mestrovic, T; Mirza-Aghazadeh-Attari, M; Mohamed, NS; Mokdad, AH; Monasta, L; Moni, MA; Moradi, M; Mougin, V; Mukoro, GD; Murillo-Zamora, E; Murray, CJL; Naimzada, MD; Najmuldeen, HHR; Natto, ZS; Negoi, I; Hien, QN; Nikolouzakis, TK; Olufadewa, II; Padubidri, JR; Pandey, A; Parikh, RR; Hoang, TP; Pollok, RCG; Rahimi, M; Rahimi-Movaghar, V; Rahman, M; Rahmani, S; Rashidi, M-M; Rawaf, S; Rickard, J; Rouientan, H; Roy, S; Saddik, BA; Saeed, U; Saleh, MA; Salehi, S; Samy, AM; Sanabria, J; Sankararaman, S; Schumacher, AE; Senthilkumaran, S; Shah, PA; Shool, S; Sibhat, MM; Sidamo, NB; Singh, JA; Socea, B; Solomon, Y; Sreeram, S; Tabatabaei, SM; Tan, K-K; Tavangar, SM; Tefera, YM; Thomas, NK; Ticoalu, JHV; Tsegay, GM; Tsegaye, D; Ullah, S; Usman, AN; Valizadeh, R; Veroux, M; Verras, G-I; Vos, T; Wang, M; Wang, S; Wickramasinghe, DP; Yahya, G; Zare, I; Zarrintan, A; Zhang, Z-J; Dirac, MA (2024) Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021. LANCET GASTROENTEROLOGY & HEPATOLOGY, 9 (9). pp. 825-858. ISSN 2468-1253 https://doi.org/10.1016/S2468-1253(24)00157-2
SGUL Authors: Pollok, Richard Charles G

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (4MB) | Preview
[img]
Preview
PDF (Supplementary appendix) Supplemental Material
Download (1MB) | Preview

Abstract

Background Appendicitis is a common surgical emergency that poses a large clinical and economic burden. Understanding the global burden of appendicitis is crucial for evaluating unmet needs and implementing and scaling up intervention services to reduce adverse health outcomes. This study aims to provide a comprehensive assessment of the global, regional, and national burden of appendicitis, by age and sex, from 1990 to 2021. Methods Vital registration and verbal autopsy data, the Cause of Death Ensemble model (CODEm), and demographic estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) were used to estimate cause-specific mortality rates (CSMRs) for appendicitis. Incidence data were extracted from insurance claims and inpatient discharge sources and analysed with disease modelling meta-regression, version 2.1 (DisMod-MR 2.1). Years of life lost (YLLs) were estimated by combining death counts with standard life expectancy at the age of death. Years lived with disability (YLDs) were estimated by multiplying incidence estimates by an average disease duration of 2 weeks and a disability weight for abdominal pain. YLLs and YLDs were summed to estimate disability-adjusted life-years (DALYs). Findings In 2021, the global age-standardised mortality rate of appendicitis was 0·358 (95% uncertainty interval [UI] 0·311–0·414) per 100 000. Mortality rates ranged from 1·01 (0·895–1·13) per 100 000 in central Latin America to 0·054 (0·0464–0·0617) per 100 000 in high-income Asia Pacific. The global age-standardised incidence rate of appendicitis in 2021 was 214 (174–274) per 100 000, corresponding to 17 million (13·8–21·6) new cases. The incidence rate was the highest in high-income Asia Pacific, at 364 (286–475) per 100 000 and the lowest in western sub-Saharan Africa, at 81·4 (63·9–109) per 100 000. The global age-standardised rates of mortality, incidence, YLLs, YLDs, and DALYs due to appendicitis decreased steadily between 1990 and 2021, with the largest reduction in mortality and YLL rates. The global annualised rate of decline in the DALY rate was greatest in children younger than the age of 10 years. Although mortality rates due to appendicitis decreased in all regions, there were large regional variations in the temporal trend in incidence. Although the global age-standardised incidence rate of appendicitis has steadily decreased between 1990 and 2021, almost half of GBD regions saw an increase of greater than 10% in their age-standardised incidence rates. Interpretation Slow but promising progress has been observed in reducing the overall burden of appendicitis in all regions. However, there are important geographical variations in appendicitis incidence and mortality, and the relationship between these measures suggests that many people still do not have access to quality health care. As the incidence of appendicitis is rising in many parts of the world, countries should prepare their health-care infrastructure for timely, high-quality diagnosis and treatment. Given the risk that improved diagnosis may counterintuitively drive apparent rising trends in incidence, these efforts should be coupled with improved data collection, which will also be crucial for understanding trends and developing targeted interventions. Funding Bill and Melinda Gates Foundation.

Item Type: Article
Additional Information: © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: LANCET GASTROENTEROLOGY & HEPATOLOGY
ISSN: 2468-1253
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
OPP1152504Bill and Melinda Gates Foundationhttp://dx.doi.org/10.13039/100000865
Web of Science ID: WOS:001381586300001
URI: https://openaccess.sgul.ac.uk/id/eprint/117141
Publisher's version: https://doi.org/10.1016/S2468-1253(24)00157-2

Actions (login required)

Edit Item Edit Item